Glaxo preps for next HGS takeover move; J&J yanks app for new Velcade use in EU;

@FiercePharma: Spanish drugmakers can't grow at home, so they're looking for international expansion--Bloomberg. More | Follow @FiercePharma

> GlaxoSmithKline ($GSK) is lining up 12 nominees to replace Human Genome Sciences' ($HGSI) entire board, but will wait till HGS' auction process wraps up before it makes another move toward taking over the company. Report

> Johnson & Johnson ($JNJ) pulled its application to extend use of Velcade, its blood cancer drug, for use in lymphoma patients. Report

> Sanofi ($SNY) plans to sell its 19.8% stake in Yves Rocher, a consumer products company that sells cosmetics, home care products and clothing. Report

> Slovenia's Krka said sales grew by 7% during the first half of 2012 to $707 million, aided by a 24% rise in Russian revenues. Report

> Lupin won FDA approval to sell its version of the Pfizer ($PFE) nerve-pain drug Lyrica. Report

> European regulators expanded approval for Eisai's epilepsy drug Zonegran to include its use on its own, rather than as an add-on to other treatments. Report

> Cardiome Pharma ($CRME) said CEO Doug Janzen left the company and will be replaced for now by interim CEO William Hunter. Report

> Dendreon ($DNDN) CEO John Johnson officially took over the chairman's role at the company. Report

Biotech News

 @FierceBiotech: Nanofactories can synthesize drugs within the body. More | Follow @FierceBiotech

@JohnCFierce: Roche move spotlights NJ's shrinking role in biopharma R&D. Article | Follow @JohnCFierce

 @RyanMFierce: Software could provide a new measuring tool for Parkinson's during clinical trials. Story | Follow @RyanMFierce

> Sanofi sharpens R&D budget ax as it prepares to cut up to 2,000 jobs. News

> Dr. Reddy's maps out ambitious global plans for biosimilars. Article

> CEO at troubled Cardiome exits in midst of reorganization. Story

Medical Device News

@FierceMedDev: We have extended the nomination deadline for the 15 fiercest medical device developers to July 13. Spread the word. Survey | Follow @FierceMedDev

 @DamianFierce: MDxHealth has signed a deal with Merck KGaA to provide companion diagnostics for a pipeline cancer drug. More | Follow @DamianFierce

> FDA says device-ID plan a 'game-changer.' Story 

> Israeli devicemaker launches smartphone that monitors vitals. Article

> FDA approves OraSure's at-home HIV test. News

Vaccines News

> In $69M IPO bid, GlobeImmune spotlights therapeutic vaccines. Story

> Group tackles dengue vaccine pricing. More

> Soligenix, Infectious Disease Research Institute partner to combat anthrax. Article

> FDA gives Argos green light for kidney cancer immunotherapy. News

Pharma Manufacturing News

 @EricPFierce: China tainted drug capsule scandal leads to new responsibilities for drugmakers. Report | Follow @EricPFierce

> FDA gets device, but not drug tracking .More

> Budget chainsaw may miss Sanofi manufacturing. News

> Glaxo manufacturing must meet special dictates. Story

CRO News

 @NesaNFierce: Argentina is becoming more than the birthplace of Tango, growing in terms of outsourcing. More | Follow @NesaNFierce

> Pernix Therapeutics offers $4.9M for CMO Great Southern Laboratories. Story

> ScinoPharm to build $37M Taiwan plant for cancer injectables. Article

> CMO execs reflect on changing manufacturing front. More

Drug Delivery News

> UPenn turns plant protein into drug-delivery tech. Item

> pSivida eyes FDA approval with trial for Durasert-delivered drug. Story

> InVivo looks to get gel-delivered pain drug on U.S. market. Article

> Northwestern docs deliver siRNA with lotion to stymie cancer. More

> Researchers develop gel to deliver male contraceptive. Story

And Finally... Teach an old bee new tricks, and its brain starts acting younger, researchers found. Report